Sarepta Therapeutics to Present at the UBS Biopharma Conference
02 Novembre 2023 - 1:30PM
Business Wire
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in
precision genetic medicine for rare diseases, today announced that
senior management will participate in a fireside chat at the UBS
Biopharma Conference on Thursday, Nov. 9, 2023 at 9:00 a.m. E.T.
The fireside chat will be held at the Fontainebleau Miami Beach in
Miami Beach, Fla.
The presentation will be webcast live under the Events &
Presentations section of the investor relations section of
Sarepta’s website at
https://investorrelations.sarepta.com/events-presentations and will
be archived there following the presentation for 90 days. Please
connect to Sarepta's website several minutes prior to the start of
the broadcast to ensure adequate time for any software download
that may be necessary.
About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic
medicine for rare diseases that devastate lives and cut futures
short. We hold leadership positions in Duchenne muscular dystrophy
(DMD) and limb-girdle muscular dystrophies (LGMDs), and we
currently have more than 40 programs in various stages of
development. Our vast pipeline is driven by our multi-platform
Precision Genetic Medicine Engine in gene therapy, RNA and gene
editing. For more information, please visit www.sarepta.com or
follow us on Twitter, LinkedIn, Instagram and Facebook.
Internet Posting of Information
We routinely post information that may be important to investors
in the 'For Investors' section of our website at www.sarepta.com.
We encourage investors and potential investors to consult our
website regularly for important information about us.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231102269533/en/
Investor Contact: Ian Estepan, 617-274-4052
iestepan@sarepta.com
Media Contact: Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com
Grafico Azioni Sarepta Therapeutics (NASDAQ:SRPT)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Sarepta Therapeutics (NASDAQ:SRPT)
Storico
Da Mag 2023 a Mag 2024